Well then I think you'll agree that we'll pretty e
Post# of 72440
$15M upfront + phase 3 trial costs in addition to milestones and royalties is probably quite realistic for a B indication. Others on iHub such as BioHedge have posited similar numbers.
I'll be more than happy to dine on pie in the sky when we get there. For now let's work on clawing our way back above a $100M market cap.
Go IPIX!